Fine-needle aspiration of the thyroid: today and tomorrow

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 22, Issue 6, 2008, Pages 929-939

  Baloch, Zubair W ^a   LiVolsi, Virginia A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

fine needle aspiration; thyroid

Indexed keywords

B RAF KINASE; DNA; PROTEIN PATCHED; PROTEIN RET;

ANAPLASTIC CARCINOMA; ASPIRATION BIOPSY; AUTOIMMUNE THYROIDITIS; CANCER SIZE; CYTODIAGNOSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DNA DETERMINATION; DNA MICROARRAY; GOITER; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC THYROIDITIS; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; ONCOCYTOMA; PALPATION; REVIEW; THYROID ADENOMA; THYROID CANCER; THYROID DISEASE; THYROID HYPERPLASIA; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; THYROIDITIS; TREATMENT INDICATION;

ADENOMA, OXYPHILIC; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY, FOLLICULAR; GRAVES DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; THYROID DISEASES; THYROID NODULE; THYROIDITIS, AUTOIMMUNE;

EID: 56649103897     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2008.09.011     Document Type: Review

References (58)

1. Baloch Z.W., Cibas E.S., Clark D.P., et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal 5 (2008) 6
2. Cooper D.S., Doherty G.M., Haugen B.R., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 109-142
3. Baskin H.J., and Duick D.S. The endocrinologists' view of ultrasound guidelines for fine needle aspiration. Thyroid 16 (2006) 207-208
4. Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Diagnostic Cytopathology 15 (1996) 84-89
5. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrine Practice 12 (2006) 63-102
6. Murray D. The thyroid gland (1998), Blackwell Science, Malden, MA 295-380
7. Baloch Z., and LiVolsi V.A. Pathology of the thyroid gland (2002), Churchill Livingston, Philadelphia, PA 61-88
8. Kini S.R. Guides to clinical aspiration biopsy thyroid. 2nd edn. (1996), Igaku-Shoin, New York, NY
9. Layfield L.J., Wax T., and Jones C. Cytologic distinction of goiterous nodules from morphologically normal thyroid: analyses of cytomorphologic features. Cancer 99 (2003) 217-222
10. Baloch Z.W., Sack M.J., Yu G.H., et al. Fine-needle aspiration of thyroid: an institutional experience. Thyroid 8 (1998) 565-569
11. Oertel Y.C., and Oertel J.E. Thyroid cytology and histology. Baillière's Best Practice & Research. Clinical Endocrinology & Metabolism 14 (2000) 541-557
12. Centeno B.A., Szyfelbein W.M., Daniels G.H., et al. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls. Acta Cytologica 40 (1996) 1189-1197
13. Anderson S.R., Mandel S., LiVolsi V.A., et al. Can cytomorphology differentiate between benign nodules and tumors arising in Graves' disease?. Diagnostic Cytopathology 31 (2004) 64-67
14. Kim W.B., Han S.M., Kim T.Y., et al. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Clinical Endocrinology 60 (2004) 719-725
15. Cantalamessa L., Baldini M., Orsatti A., et al. Thyroid nodules in Graves disease and the risk of thyroid carcinoma. Archives of Internal Medicine 159 (1999) 1705-1708
16. Carson H.J., Castelli M.J., and Gattuso P. Incidence of neoplasia in Hashimoto's thyroiditis: a fine-needle aspiration study. Diagnostic Cytopathology 14 (1996) 38-42
17. Liu L.H., Bakhos R., and Wojcik E.M. Concomitant papillary thyroid carcinoma and Hashimoto's thyroiditis. Seminars in Diagnostic Pathology 18 (2001) 99-103
18. Kumar N., Ray C., and Jain S. Aspiration cytology of Hashimoto's thyroiditis in an endemic area. Cytopathology 13 (2002) 31-39
19. MacDonald L., and Yazdi H.M. Fine needle aspiration biopsy of Hashimoto's thyroiditis. Sources of diagnostic error. Acta Cytologica 43 (1999) 400-406
20. Mechler C., Bounacer A., Suarez H., et al. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements. British Journal of Cancer 85 (2001) 1831-1837
21. Kumarasinghe M.P., and De Silva S. Pitfalls in cytological diagnosis of autoimmune thyroiditis. Pathology 31 (1999) 1-8
22. Baloch Z.W., Fleisher S., LiVolsi V.A., et al. Diagnosis of 'follicular neoplasm': a gray zone in thyroid fine-needle aspiration cytology. Diagnostic Cytopathology 26 (2002) 41-44
23. Renshaw A.A. Follicular lesions of the thyroid. American Journal of Clinical Pathology 115 (2001) 782-785
24. Sidawy M.K., Del Vecchio D.M., and Knoll S.M. Fine-needle aspiration of thyroid nodules: correlation between cytology and histology and evaluation of discrepant cases. Cancer 81 (1997) 253-259
25. Pu R.T., Yang J., Wasserman P.G., et al. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?. Diagnostic Cytopathology 34 (2006) 330-334
26. Deveci M.S., Deveci G., LiVolsi V.A., et al. Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-Up. Cytojournal 3 (2006) 9
27. Clary K.M., Condel J.L., Liu Y., et al. Interobserver variability in the fine needle aspiration biopsy diagnosis of follicular lesions of the thyroid gland. Acta Cytologica 49 (2005) 378-382
28. Tuttle R.M., Lemar H., and Burch H.B. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 8 (1998) 377-383
29. Yang J., Schnadig V., Logrono R., et al. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer 111 (2007) 306-315
30. Elliott D.D., Pitman M.B., Bloom L., et al. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: a cytomorphologic study of 139 cases with statistical analysis. Cancer 108 (2006) 102-109
31. Oertel Y.C. Fine-needle aspiration in the evaluation of thyroid neoplasms. Endocrine Pathology 8 (1997) 215-224
32. Das D.K., Mallik M.K., Sharma P., et al. Papillary thyroid carcinoma and its variants in fine needle aspiration smears. A cytomorphologic study with special reference to tall cell variant. Acta Cytologica 48 (2004) 325-336
33. Baloch Z.W., and LiVolsi V.A. Cytologic and architectural mimics of papillary thyroid carcinoma. Diagnostic challenges in fine-needle aspiration and surgical pathology specimens. American Journal of Clinical Pathology 125 Suppl (2006) S135-S144
34. Albores-Saavedra J., and Wu J. The many faces and mimics of papillary thyroid carcinoma. Endocrine Pathology 17 (2006) 1-18
35. Zacks J.F., de las Morenas A., Beazley R.M., et al. Fine-needle aspiration cytology diagnosis of colloid nodule versus follicular variant of papillary carcinoma of the thyroid. Diagnostic Cytopathology 18 (1998) 87-90
36. Solomon A., Gupta P.K., LiVolsi V.A., et al. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Diagnostic Cytopathology 27 (2002) 143-148
37. Collins B.T., Cramer H.M., Tabatowski K., et al. Fine needle aspiration of medullary carcinoma of the thyroid. Cytomorphology, immunocytochemistry and electron microscopy. Acta Cytologica 39 (1995) 920-930
38. Wan S.K., Chan J.K., and Tang S.K. Paucicellular variant of anaplastic thyroid carcinoma. A mimic of Reidel's thyroiditis. American Journal of Clinical Pathology 105 (1996) 388-393
39. LiVolsi V.A. Surgical pathology of the thyroid (1990), WB Saunders, Philadelphia, PA
40. Cheung C.C., Ezzat S., Freeman J.L., et al. Immunohistochemical diagnosis of papillary thyroid carcinoma. Modern Pathology 14 (2001) 338-342
41. Sapio M.R., Guerra A., Posca D., et al. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocrine-Related Cancer 14 (2007) 1089-1097
42. Barroeta J.E., Baloch Z.W., Lal P., et al. Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis. Endocrine Pathology 17 (2006) 225-234
43. Nikiforov Y.E. RET/PTC rearrangement in thyroid tumors. Endocrine Pathology 13 (2002) 3-16
44. Fischer A.H., Bond J.A., Taysavang P., et al. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. The American Journal of Pathology 153 (1998) 1443-1450
45. Zou M., Shi Y., and Farid N.R. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer 73 (1994) 176-180
46. Motomura T., Nikiforov Y.E., Namba H., et al. ret rearrangements in Japanese pediatric and adult papillary thyroid cancers. Thyroid 8 (1998) 485-489
47. Domingues R., Mendonca E., Sobrinho L., et al. Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma. Cytopathology 16 (2005) 27-31
48. Sapio M.R., Posca D., Raggioli A., et al. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clinical Endocrinology 66 (2007) 678-683
49. Pizzolanti G., Russo L., Richiusa P., et al. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Thyroid 17 (2007) 1109-1115
50. Papotti M., Volante M., Giuliano A., et al. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. The American Journal of Surgical Pathology 24 (2000) 1615-1621
51. Wirtschafter A., Schmidt R., Rosen D., et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. [see comments]. The Laryngoscope 107 (1997) 95-100
52. Elisei R., Romei C., Vorontsova T., et al. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. Journal of Clinical Endocrinology & Metabolism 86 (2001) 3211-3216
53. Inaba M., Umemura S., Satoh H., et al. Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type. Pathology International 53 (2003) 146-153
54. Daum G., Eisenmann-Tappe I., Fries H.W., et al. The ins and outs of Raf kinases. Trends in Biochemical Sciences 19 (1994) 474-480
55. Cohen Y., Xing M., Mambo E., et al. BRAF mutation in papillary thyroid carcinoma. Journal of the National Cancer Institute 95 (2003) 625-627
56. Kimura E.T., Nikiforova M.N., Zhu Z., et al. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research 63 (2003) 1454-1457
57. Fagin J.A. How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy. The Journal of Endocrinology 183 (2004) 249-256
58. Lubitz C.C., Ugras S.K., Kazam J.J., et al. Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. The Journal of Molecular Diagnostics 8 (2006) 490-498 quiz 528